Drug
SL 325
SL 325: highest development phase Phase 2, developed by Shattuck Labs, Inc.. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shattuck Labs, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| SL-325 NCT07934017 | Phase 2 | Hidradenitis Suppurativa (HS) |
| SL-325 NCT07753850 | Phase 2 | Crohn's Disease |
Latest
No recent events.
Follow SL 325 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.